WEDNESDAY, Aug. 16, 2023 (HealthDay News) — All infants should receive the new long-acting preventive monoclonal antibody for respiratory syncytial virus (RSV), the nation’s leading pediatrics group said. The American Academy of Pediatrics (AAP) urged that access to the new medication, called nirsevimab, be equitable. RSV is common, contagious andContinue Reading
TUESDAY, Aug. 15, 2023 (HealthDay News) — As experts begin preparing for another season of viruses, they now know that even healthy infants with no underlying health issues are at risk for severe respiratory syncytial virus (RSV). New research finds that most infants who were admitted last fall to anContinue Reading
TUESDAY, Aug. 15, 2023 (HealthDay News) — Millions of Americans are addicted to drugs or alcohol, and millions more struggle with an addicted family member or friend, a new poll finds. Two-thirds of those surveyed said either they or a family member have been addicted to alcohol or drugs, beenContinue Reading
MONDAY, Aug. 14, 2023 (HealthDay News) — Psilocybin, the active ingredient in “magic” mushrooms, is getting renewed interest as a potential treatment for various health conditions. Now, a new research review argues that migraines should be added to that list. Psilocybin mushrooms have long been used recreationally as hallucinogens —Continue Reading
MONDAY, Aug. 14, 2023 (HealthDay News) — For people with severe alcohol use disorder, a new gene therapy trial could lead to an effective treatment that would involve chemically rebalancing the area of the brain associated with addiction. “With alcohol alone, there’s generally more than 100,000 deaths [in the UnitedContinue Reading
FRIDAY, Aug. 11, 2023 (HealthDay News) – As demand for the wildly popular weight-loss drug Wegovy continues to climb, drug maker Novo Nordisk said Thursday that it will continue restrictions on starter doses of the medication into 2024. The new plan extends by months existing restrictions and means patients whoContinue Reading
FRIDAY, Aug. 11, 2023 (HealthDay News) – A bankruptcy deal that would have shielded the family behind the company that makes Oxycontin from civil lawsuits was temporarily blocked by the U.S. Supreme Court on Thursday. President Joe Biden had asked for a delay in approval of the nationwide settlement, whichContinue Reading
THURSDAY, Aug. 10, 2023 (HealthDay News) — Most people with appendicitis who are given antibiotics — instead of having their appendix removed — fare well over the long haul, new research indicates. The conclusion follows roughly two decades spent tracking patient outcomes in Sweden. The study found that among thoseContinue Reading
THURSDAY, Aug. 10, 2023 (HealthDay News) — Older adults who use certain heartburn medications for years may have a heightened risk of developing dementia, a new study suggests. The study, published Aug. 9 in the journal Neurology, is the latest to point to potential hazards from prolonged use of medicationsContinue Reading
THURSDAY, Aug. 10, 2023 (HealthDay News) — Modern antidepressants could be effective for long-term treatment of some patients with bipolar disorder, a new trial suggests. Current guidelines discourage use of antidepressants in these patients, over concerns that the drugs will trigger a manic episode. But bipolar patients who remained onContinue Reading